Wednesday, June 10, 2026

pharma Β· Oral Mucositis Β· Complex Cardiovascular Surgery With Cardiopulmonary Bypass

CSL Behring

CSL Behring clinical programs β€” 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Marburg, DE HQ
EMA registrant Type
Company details
Status
Public
HQ
Marburg, DE
Programs
7
Drugs
6
Patents
25
Intelligence Β· Clinical Programs

CSL Behring projects

2 ClinicalTrials.gov programs sponsored by CSL Behring.

CSL Behring has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. ALD518

    CSL Behring GmbH

    Oral Mucositis

    phase 2 mab terminated

    1 trial
  2. BMS-945429 Placebo

    CSL Behring GmbH

    Rheumatoid Arthritis

    phase 2 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does CSL Behring have?

2 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.